You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
With the rollout of Insitome's first app, consumers have the chance to explore their heritage in a new context that could reshape the ancestry testing market.
The company has developed a suite of initial products focused on ancestry that will compete with offerings from 23andMe, AncestryDNA, and Family Tree DNA.
At the Guardian, Samantha Gillison writes that she took a DNA ancestry test and found she was exactly what she thought she was.
A recent study examining the websites of 30 DTC genomics firms found that many do not follow international recommendations for disclosing information to customers.
The company said the investments will support growth in its AncestryDNA genetic genealogy offering.
Consumer genetics companies field law enforcement requests, the Associated Press reports.
At the New York Times, Marie Tae McDermott writes about her experience with genetic testing as an adoptee.
Researchers from Brigham and Women's and Harvard surveyed more than 1,600 new customers of 23andMe or Pathway Genomics in the US, of whom 80 were adopted.
In PLOS this week: researchers trace inherited cancer syndrome to a German couple born in the 1700s, loci involved in exceptional longevity, and more.
Four families from across the US have an inherited cancer syndrome that researchers traced to a couple that emigrated from Germany in the 1700s.
New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.
The US National Institutes of Health has a new initiative to address structural racism in biomedical research.
According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.
In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.